Abstract:
This is the second in a multi-part series of pragmatic white papers to address the 2017 Drug Supply Chain Security Act (DSCSA) mandates for unit-level serialization, the Big 3 and HDMA wholesaler expectations, and the realities of serialization and aggregation requirements for pharmaceutical manufacturers.